The largest pharmaceutical company in Ukraine received €12M from Ukrainian and Latvian banks to construct a plant in Spain. Thanks to the West Bridge program, Ukrainian businesses continue to develop in EU countries. Another of the program’s significant projects is financing a new pharmaceutical plant for the largest Ukrai... #BusinessDevelopment #Farmak #LoansforBusiness #PharmaceuticalCompany #PivdennyWestBridge #ukrainianbusiness
Farmak invests more than €20M in Spain. Ukrainian Pharmaceutical company Farmak is investing over €20M to construct a new plant in Spain. The new facility will be built in the suburbs of Barcelona and will start operating in early 2024, acc... #Farmak #FarmakInvestments #MedicineProduction
The EBRD lends €20M to Ukrainian pharmaceutical company Farmak. The EBRD is lending €20M to a leading Ukrainian pharmaceuticals manufacturer under its €2B Resilience and Livelihoods Framework, supporting countries affected by the war in Ukraine. The financing, wh... #ebrd #EBRDloan #Farmak #FarmaKukraine
Farmak invested more than $1.2M in HealthCare projects and startups. According to Farmak director Volodymyr Kostyuk, the company started investing in the venture capital market in 2020. The company is interested in advanced rapid diagnostics, digital medicine, and inte... #Farmak #FarmakInvestments
Ukrainian pharmaceutical company Farmak has expanded to Vietnam. The leading pharmaceutical manufacturer and exporter of medicines, has opened a representative office in Vietnam. The company has been active in the Vietnamese market since 2007, when it sold 25 of it... #Farmak #FarmakinVietnam #FarmaKukraine
Farmak, a leading Ukrainian pharmaceuticals company, will donate $500,000 to the Kiev School of Economics (KSE) to fund a new campus and improve existing programs , the company said in a press release. “By supporting such projects, we are contributing to the achievement of the Global Sustainable Development Goals, one of the tasks of which is to improve t... #Farmak #FarmakDonation #KSE #Kyivschoolofeconomics